Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Ray, Brettle"'
Autor:
Eduard J Beck, Sundhiya Mandalia, Roshni Sangha, Mike Youle, Ray Brettle, Mark Gompels, Margaret Johnson, Anton Pozniak, Achim Schwenk, Stephen Taylor, John Walsh, Ed Wilkins, Ian Williams, Brian Gazzard, NPMS-HHC Steering Group
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47376 (2012)
AimInvestigate the cost and effects of a single-pill versus two- or three pill first-line antiretroviral combinations in reducing viral load, increasing CD4 counts, and first-line failure rate associated with respective regimens at 6 and 12 months.Me
Externí odkaz:
https://doaj.org/article/522a57f424db4fd19a4e14c6ab92e719
Autor:
Eduard J Beck, Sundhiya Mandalia, Gary Lo, Peter Sharott, Mike Youle, Jane Anderson, Guy Baily, Ray Brettle, Martin Fisher, Mark Gompels, George Kinghorn, Margaret Johnson, Brendan McCarron, Anton Pozniak, Alan Tang, John Walsh, David White, Ian Williams, Brian Gazzard, NPMS-HHC Steering Group
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e20200 (2011)
Calculate time to first-line treatment failure, annual cost and cost-effectiveness of NNRTI versus PIboosted first-line HAART regimens in the UK, 1996-2006.Population costs for HIV services are increasing in the UK and interventions need to be effect
Externí odkaz:
https://doaj.org/article/c0f5a87354ef4995899ebc3981462693
Autor:
Eduard J Beck, Sundhiya Mandalia, Roshni Sangha, Peter Sharott, Mike Youle, Guy Baily, Ray Brettle, Mark Gompels, Margaret Johnson, Brendan McCarron, Ed Ong, Anton Pozniak, Achim Schwenk, Stephen Taylor, John Walsh, Ed Wilkins, Ian Williams, Brian Gazzard, NPMS-HHC Steering Group
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e27830 (2011)
To calculate use, cost and cost-effectiveness of people living with HIV (PLHIV) starting routine treatment and care before starting combination antiretroviral therapy (cART) and PLHIV starting first-line 2NRTIs+NNRTI or 2NRTIs+PI(boosted), comparing
Externí odkaz:
https://doaj.org/article/45b6ce323fde4cbc804b4856f4bde7d1
Autor:
Sundhiya Mandalia, Roshni Mandalia, Gary Lo, Tim Chadborn, Peter Sharott, Mike Youle, Jane Anderson, Guy Baily, Ray Brettle, Martin Fisher, Mark Gompels, George Kinghorn, Margaret Johnson, Brendan McCarron, Anton Pozniak, Alan Tang, John Walsh, David White, Ian Williams, Brian Gazzard, Eduard J Beck, NPMS-HHC Steering Group
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15677 (2010)
The number of people living with HIV (PLHIV) is increasing in the UK. This study estimated the annual population cost of providing HIV services in the UK, 1997-2006 and projected them 2007-2013.Annual cost of HIV treatment for PLHIV by stage of HIV i
Externí odkaz:
https://doaj.org/article/36089c4b8b394160b4d279c871b63644
Autor:
Abdel, Babiker, Janet, Darbyshire, Patrizio, Pezzotti, Kholoud, Porter, Giovanni, Rezza, Sarah A, Walker, Valerie, Beral, Roel, Coutinho, Julia, Del Amo, Noël, Gill, Christine, Lee, Laurence, Meyer, Freya, Tyrer, Francois, Dabis, Rodolphe, Thiebaut, Sylvie, Lawson-Aye, Faroudy, Boufassa, Osamah, Hamouda, Klaus, Fischer, Giota, Touloumi, Angelos, Hatzakis, Anastasia, Karafoulidou, Olga, Katsarou, Ray, Brettle, Jorge, del Romero, Maria, Prins, Birgit, van Benthem, Ole, Kirk, Court, Pederson, Idelfonso, Hernández Aguado, Santiago, Pérez-Hoyos, Anne, Eskild, Johan N, Bruun, Mette, Sannes, Caroline, Sabin, Anne M, Johnson, Andrew N, Phillips, Patrick, Francioli, Philippe, Vanhems, Mathias, Egger, Martin, Rickenbach, David, Cooper, John, Kaldor, Lesley, Ashton, Jeanette, Vizzard, Roberto, Muga, Nicholas E, Day, Daniela, De Angelis
Publikováno v:
International journal of epidemiology, 31(5), 951-958. Oxford University Press
BACKGROUND: Although studies have reported large reductions in the risks of AIDS and death since the introduction of potent anti-retroviral therapies, few have evaluated whether this has been similar for all AIDS-defining diseases. We wished to evalu
Autor:
Anders Blaxhult, Zoe Fox, Jens D Lundgren, F Antunes, Amanda Mocroft, P Francioli, d'Arminio Monforte A, Jacqueline M. Parkin, Ole Kirk, Ray Brettle
Publikováno v:
AIDS. 16:1663-1671
OBJECTIVES: The causes of death among HIV-positive patients may have changed since the introduction of highly active antiretroviral therapy (HAART). We investigated these changes, patients who died without an AIDS diagnosis and factors relating to pr
Autor:
Peng Lee Yap, Derek Middleton, J. Roy Robertson, Ray Brettle, Sarah F. Lockett, Andrew J. Leigh Brown
Publikováno v:
ResearcherID
Genetic variation at the human leukocyte antigen (HLA) loci has been shown to be an important risk factor for progression to HIV disease, but its significance in infection is less well understood. We have investigated its role in HIV transmission in
Autor:
Ray Brettle
Publikováno v:
Medicine. 29:12-17
Publikováno v:
European Journal of Gastroenterology & Hepatology. 10:485-490
It is unclear whether co-infection with hepatitis C virus (HCV) can influence HIV related morbidity or mortality, either by accelerating HIV-related disease progression, or by contributing to end stage liver disease. The aim of this study was to exam
Publikováno v:
Statistics in Medicine. 16:2459-2474
In this paper, we look at the incidence and predictive factors of pre-AIDS mortality among HIV-infected individuals, and injecting drug users (IDUs) in particular, and compare IDUs with non-IDUs. 627 patients (73 per cent IDUs) of the Edinburgh City